How is your energy right now on a scale from 1 to 10
Get your custom peptide protocol: Tailored to your body and goals Precise dosing and cycle length Safe stacking combinations Backed by peer-reviewed studies Ready in under 2 minutes The Verdict: Retatrutide Wins on Trial Data, Zepbound Wins on Availability Retatrutide produced the largest average weight loss reported in a Phase 2 obesity trial to date, but it cannot be legally prescribed for weight loss as of June 2026
Oral administration of Akk11 enhances the metabolic benefits of GLP-1RA in db/db mice The increased abundance of AKK prompted us to explore whether supplementation with AKK could enhance the therapeutic efficacy of GLP1-RA
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial [published correction appears in lancet
Compared with people taking metformin, among those taking GLP-1 RAs, the analysis found a 26% reduction in all causes of death
The use of ferroptosis activator erastin or RSL3 can promote cancer cell death by inducing ferroptosis
